Systemic and coronary haemodynamics and pharmacodynamics of enalapril and enalaprilat in congestive heart failure.
K Chatterjee, T De Marco
Index: Drugs 39 Suppl 4 , 29-40; discussion 41-2, (1990)
Full Text: HTML
Abstract
Enalapril is an effective angiotensin-converting enzyme (ACE) inhibitor which produces salutary, beneficial haemodynamic effects in patients with congestive heart failure. Enalapril also produces beneficial neurohumoral changes, as well as improving abnormal coronary haemodynamics and myocardial energetics that are frequently encountered in these patients. Administration of enalapril once or twice daily appears to be quite effective during maintenance therapy in patients with chronic congestive heart failure.
Related Compounds
Related Articles:
2015-02-01
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 980 , 79-87, (2015)]
2014-09-01
[Drug Metab. Dispos. 42(9) , 1567-74, (2014)]
2000-01-01
[Dimens. Crit. Care Nurs. 19(2) , 22, (2000)]
Major contribution of the medial amygdala to hypertension in BPH/2J genetically hypertensive mice.
2014-04-01
[Hypertension 63(4) , 811-8, (2014)]